Back to VANGUARD GROUP INC VANGUARD GROUP INC

DNLIDNLI
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in DENALI THERAPEUTICS INC

VANGUARD GROUP INC holds 13.1M shares of DNLI (DENALI THERAPEUTICS INC), worth $215.6M as of 2025-Q4. The position was increased (+8.9% shares). DNLI represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$215.6M

Current Shares

13.1M

Total Value Change

-$110M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
13.1M
+8.9%
$215.6M0.0%$16.41
33
2025-Q3
Increased
12M
+1.5%
$174.1M0.0%$14.52
31
2025-Q2
Increased
11.8M
+0.1%
$165.2M0.0%$14.10
30
2025-Q1
Decreased
11.8M
-1.8%
$160.4M0.0%$14.78
0
2024-Q4
Increased
12M
+7.5%
$245M0.0%$20.24
33
2024-Q3
New
11.2M
-
$325.6M0.0%$29.43
43

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used